Figure 4From: Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancerProbability of PCa according to urinary biomarkers stratified by PSA level: A) Probability of PCa according to β2M stratified by PSA level, β2M ≥ 40 DU (P <0.001) B) Probability of PCa according to β2M stratified by PSA level, PGA3 ≥ 190 DU (P = 0.008) B) Probability of PCa according to PGA3 stratified by PSA level C) Probability of PCa according to MUC3 stratified by PSA level, MUC3 ≥ 185 DU (P = 0.009).Back to article page